Elgoyoushi Sayed Mohamed, Morrah Ahmed Nabawy, Kholeif Ahmed Mahmoud, Elbadry Ahmad Amr
Orthopedic Surgery Department, Faculty of Medicine, Kasr Alainy, Cairo University, Cairo, Egypt.
Trauma Case Rep. 2025 Apr 13;57:101158. doi: 10.1016/j.tcr.2025.101158. eCollection 2025 May.
This study aimed to evaluate the clinical and radiographic outcomes of tibiotalocalcaneal (TTC) nailing in diabetic patients with Charcot neuropathy and ankle fractures. A total of 84 patients underwent TTC nailing between December 2022 and June 2024. Functional outcomes were assessed using the Foot and Ankle Outcome Score (FAOS). Significant improvement was observed, increasing from a preoperative mean of 19.9 ± 3.81 to 72.6 ± 11.66 at six months postoperatively ( < 0.001). Union was achieved in 75 % of patients, with delayed union in 17.9 % and nonunion in 7.1 %. Postoperative complications included superficial infections (7.1 %) and deep infections (3.6 %). No significant correlations were found between final FAOS scores and patient demographics or diabetes-related factors. TTC nailing is a reliable treatment option for this high-risk population. Clinical trial number: not applicable.
本研究旨在评估在患有夏科氏神经病变和踝关节骨折的糖尿病患者中使用胫距跟骨（TTC）钉固定术的临床和影像学结果。2022年12月至2024年6月期间，共有84例患者接受了TTC钉固定术。使用足踝结果评分（FAOS）评估功能结果。观察到显著改善，术前平均评分为19.9±3.81，术后6个月增至72.6±11.66（<0.001）。75%的患者实现了骨愈合，17.9%的患者出现延迟愈合，7.1%的患者出现骨不连。术后并发症包括浅表感染（7.1%）和深部感染（3.6%）。最终FAOS评分与患者人口统计学特征或糖尿病相关因素之间未发现显著相关性。TTC钉固定术是这一高危人群的可靠治疗选择。临床试验编号：不适用。
